Brain tumor News
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

Displaying Stories 21 to 40 of 6,253
Previous 20           Next 20

10/11/17 Mustang CAR-T brain tumor trial gets funds to expand        

 This is one of the most promising treatments in the pipeline.

10/11/17 Immunomic Therapeutics Offers Travel Fund for Clinical Trial Patients        

 This is another of my favorite trials,  They now offer free travel to Florida for participants!

10/11/17 Areas of glioblastoma tumors correlate with separate subtypes of glioma stem cells        

 This is the type of research and thinking that can lead to major breakthroughs. Figuring out why treatments fail, and putting together intelligent combinations is the path to breakthroughs.  This research is in mice, hope they try it on people soon.

10/10/17 Medicenna Presents Clinical Data on Initial Experience from Ongoing Phase 2b Study of MDNA55        

 They did not say how the patients did, but they did report that they were able to deliver the drug to the correct place in a higher percentage of the time than in previous trials.  That was the big problem with previous trials involving convection enhanced delivery.  In the first such trial, the PRECISE trial, it was found that most or all of the patients did not get the drug to the correct place - which didn't give the drug a chance to work - so the trial failed. More recently the Tocagen trials have used CED and have vastly improved the ability to get the drug where it needs to go. Hopefully this is another step toward getting the drug to the correct place 100% of the time.

(Disclaimer: Medicenna is a sponsor of the Musella Foundation)

10/10/17 New resources for children affected by brain tumors in the family!        

 We partnered with the Pediatric Brain Tumor Foundation to distribute these animated films for any kids who either have a tumor or know someone with a tumor. Makes it easy to explain to kids what is going on.  

10/09/17 Combination Treatment Targeting Glucose in Advanced Brain Cancer Shows Promising Results in Preclinical Study        

 Interesting approach.  Works in mouse model, hope it works in human trials!

10/07/17 ABC²'s Research Showcase: INSIGhT - The First-Ever Adaptive Clinical Trial for Glioblastoma        

 This is the wave of the future in clinical trial design. They will be broadcasting the event on facebook.


10/07/17 Many new cancer drugs don't save lives        

 What these people do not understand is that for the hard to treat cancers - like glioblastoma, the cure is most likely not going to be a single drug.  It will be a combination of several treatments.  However, we can not easily test the combinations until the drugs are approved.  The huge failure is they are not tracking the results.  I feel the only way to home in on the ultimate cocktail is to track all cancer patients - the treatments they do and the outcome. Without that data we are doomed to failure.

10/05/17 Neuro-Oncologist Dr. Howard Fine wins NIH Director's Pioneer Award        

 Congratulations to one of my favorite neuro-oncs!


Well deserved!

10/03/17 FDA simplifies Institutional Review Board review requirements for physicians seeking individual patient expanded access - Drug Information Update        

 The FDA issued 3 new guidence documents relating to expanded access of experimental drugs.  This makes it a lot easier for your doctor to get permission to use them. Big step, but not enough.  

10/02/17 VBL Therapeutics Announces Positive Outcome in the Third and Final DSMC Review of Phase 3 GLOBE Trial Investigating VB-111 in Recurrent GBM        

This is a good sign - no safety problems identified and the trial will be allowed to continue until it completes.

09/29/17 Biologists identify possible new strategy for halting brain tumors        

 Interesting research.

09/29/17 I’m dying of brain cancer. I prepared to end my life. Then I kept living.        

 This is a common topic of conversation.  My views are that assisted suicide has a place - but most consider it way too early, just like this man.  You get diagnosed, read about the horrors of the diagnosis on the internet and give up.  But what is missed is that some people do beat this. There is progress every week. Just this week, we published 2 articles showing major gains:  adding CCNU to Temodar upped the average survival to 46 months.. which means half of the people lived longer than that!  And the long term results of the Optune trial showing that the 5 year survival rate, which was stuck at 5% for the last 100 years or so, is now 13%.  (Still bad, but a lot better than 5%)

09/27/17 Amazing increase in survival for newly diagnosed GBM by adding CCNU        

 This study shows an amazing increase in survival by adding ccnu to Temozolomide.  These treatments are already available and may be worth asking your doctors about now. 

09/24/17 Combination of Optune® with Temozolomide Demonstrates Unprecedented Five-Year Survival for Newly Diagnosed Glioblastoma Patients        

 The 5 year results for Optune just came out and they were unbelievably good.  This is a large study in newly diagnosed GBM patients so the results are significant. Bottom line: 5 year survival rate was 13% for the Optune (plus Temodar) group and only 5% for the Temodar alone group.  That is a major step forward.

09/24/17 How the poliovirus can be used to battle lethal cancers        

 This is one of the more exciting experimental treatments in the pipeline. We (the Musella Foundation) has funded a small part of it! 

09/19/17 New math developments lead to more improved brain cancer treatment        

 I agree completely.  Advanced math is going to be the key to finding the cure.  I think the path to the cure is having all patients tracked in the virtual trial registry, and analyzing the data to find the best combinations.  (Along with getting early access to experimental treatments)

09/14/17 Treatment nonexistent for some glioblastoma patients        

This is why we are always telling our patients to seek care at a major brain tumor center. You need experienced people taking care of you. I cringe when people tell me they are being treated at a small community hospital. Many times when staff at a community hospital calls us to ask about our copayment assistance program and we explain the covered treatments, they say "what is Optune?".  You do not want to be treated at a center that doesn't keep up.

09/11/17 DelMar Pharmaceuticals Initiates Phase 2 Clinical Trial in Newly Diagnosed MGMT-unmethylated Glioblastoma Multiforme        

 For GBM patients with unmethylated MGMT, the standard Temozolomide has a much worse chance of helping. This may be an alternative. It works similar to how Temozolomide works, but at a different spot on the chromosomes so it is not affected by the MGMT repair enzyme.

09/11/17 "Treatment Options for Glioblastoma and other Gliomas" Ben Williams' Aug 2017 Update        

 Ben Williams is a 22+ year GBM survivor who wrote an excellent book on his thoughts on how to approach a serious diagnosis.   The book talks about a lot of treatments - so it is out of date as soon as it is published.  So he puts together an update every year to keep it fresh.  Starting last year, our medical editor, Stephen Western, has taken over the updates - with Ben's approval of all changes.  We host these updates on  as a free service!  It is one of the more important articles on brain tumor treatments.   This years update is 138 pages!

We discuss this on the braintumor treatments online group:

Displaying Stories 21 to 40 of 6253
Previous 20           Next 20

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557

Website Design By
World Wide Websites